|
Pathologic accumulations of glycogen
occur in the tissues of patients with diabetes mellitus in whom the
normal cellular uptake of glucose is impaired.
Excessive storage of glycogen is also
found in genetic diseases in which there is absence of one or another of
the enzymes that constitute the Embden-Meyerhof glycolytic pathway, or
when an abnormally structured glycogen that cannot be degraded by
glycolytic enzymes is synthesized.
Intracellular accumulations of glycogen
impart a vacuolated appearance to the cytoplasm.
Since accumulations of glycogen
morphologically resemble those of water (hydropic swelling) and fat
(triglyceride under the light microscope), one of the following tests is
necessary to establish that the deposit is glycogen:
(1) application of the periodic
acid-Schiff test in which glycogen is stained reddish purple (tissues
previously digested with diastase serve as negative controls) or
(2) quantitative analysis of the glycogen
content of affected tissues.
Massive intracellular deposits of
glycogen occurring in glycogen storage disease cause affected organs
such as the liver, kidney or heart to be greatly enlarged and their
function to be ultimately compromised.
In
diabetes mellitus,
glycogen deposits are encountered in epithelium of the distal segment of
the proximal convoluted renal tubules and the descending loop of Henle,
hepaocytes, beta cells of pancreatic islets, and cardiac muscle.
Accumulation in the kidney occurs when the degree of glycosuria leads to
levels of glucose in the glomerular filtrate that exceed the rate at
which glucose is reabsorbed by epithelial cells of the renal tubules
(tubular mass).
Excessive intracellular deposits of
glycogen lipids, glycolipids, mucolipids, and mucopolysaccharides
develop in patients with genetic disorders characterized by lysosomes
with specific enzyme deficiencies that render them incapable of
hydrolyzing them.
Abnormal metabolites accumulate in
neurons of the centrals nervous system, as well as parenchymal cells of
the liver, kidney, and heart, and cells of the reticuloendothelial
system such that massive enlargement of the spleen and to a lesser
degree the lymph nodes and liver occurs.
As in the other storage diseases
attributable to gene defects, involvement may become so severe that it
is incompatible with life. These and similar diseases are considered in
greater detail in a subsequent section dealing with inborn errors of
metabolism.

|